Genomics & Proteomics

The new “iPSC Platform to Model Alzheimer’s disease Risk” (IPMAR) resource will be made available to researchers worldwide

New findings could lead to improved immunotherapy options for male patients

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine

Direct in sample sequencing, or DISS, is a high-demand and transformative technology that unlocks library-prep free research possibilities across a variety of new use cases

Join Today’s Clinical Lab with experts from Targeted Genomics and DNA Genotek for an in-depth discussion on the role of Genetic Health Risk Tests (GHR) in advancing personalized healthcare, and how integrating sample collection devices validated for their analytical performance can enhance the reliability and accessibility of GHRs

This new publication sets the standard, enabling more personalized and targeted breast cancer prevention and detection

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases

Small changes in fragmentation lead to significant shifts in data quality. See the comparison

Professor Mark Peifer explains why understanding the history of eugenics is critical for up-and-coming scientists

With whole genome sequencing gaining traction in clinical labs, consistent sample prep is more important than ever

The customized solution enables the team to make informed variant interpretations and treatment recommendations

New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration

Advanced sequencing solutions make high-precision NGS more accessible for labs of all sizes

EpiPlex is first platform to offer multitarget, quantitative analysis of RNA modifications to provide comprehensive detection and characterization of the epitranscriptome

The GUARDIAN offers proof of principle that we can implement advanced genomic testing on a large scale

Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies

The new molecular findings are essential for further developing diagnostic tools and imaging techniques to detect and monitor Huntington’s disease

Nanopore-based sensors could transform diagnostics